Envoy Medical (NASDAQ:COCH – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Envoy Medical and Sintx Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Envoy Medical | 1 | 1 | 1 | 0 | 2.00 |
| Sintx Technologies | 1 | 0 | 3 | 0 | 2.50 |
Envoy Medical currently has a consensus target price of $2.25, suggesting a potential upside of 233.83%. Sintx Technologies has a consensus target price of $9.33, suggesting a potential upside of 502.15%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Envoy Medical.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Envoy Medical | $234,000.00 | 221.44 | -$23.76 million | ($1.01) | -0.67 |
| Sintx Technologies | $1.02 million | 6.56 | -$10.36 million | ($5.07) | -0.31 |
Sintx Technologies has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Envoy Medical has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500.
Institutional & Insider Ownership
8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 7.1% of Envoy Medical shares are held by company insiders. Comparatively, 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Envoy Medical and Sintx Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Envoy Medical | -9,875.64% | N/A | -177.92% |
| Sintx Technologies | -1,058.60% | -366.49% | -115.04% |
Summary
Sintx Technologies beats Envoy Medical on 9 of the 14 factors compared between the two stocks.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
About Sintx Technologies
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
